ReviewAdvances in experimental medicine and biology2026
Periodontal Disease and Osteoporosis: A Bidirectional Relationship.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- FAM30A Induces Inflammation and Oxidative Damage in PDLSCs by Targeting miR-424-5p.International dental journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoporosis (OP) and periodontitis (PD) are two prevalent diseases with significant public health implications, particularly among aging populations. Osteoporosis is a condition that can affect any bone, characterized by decreased bone mineral density (BMD) and deterioration of the bone architecture, resulting in weaker bones and a higher risk of fractures. Periodontitis is a chronic inflammatory condition affecting the supporting structures of the teeth, such as the gingiva, periodontal ligament, and alveolar bone, often leading to tooth loss if left untreated.Recent studies have suggested an interrelationship between these conditions, rooted in shared biological mechanisms. Both diseases involve an imbalance in bone remodeling processes, with excessive activity of osteoclasts over osteoblasts, leading to bone resorption. In osteoporosis, this imbalance is systemic, while in periodontitis, it is localized to the jawbone.Shared risk factors, such as aging, hormonal changes (e.g., postmenopausal estrogen deficiency), and lifestyle factors, like smoking and poor nutrition, further strengthen this association. Additionally, osteoporosis may exacerbate periodontitis by reducing alveolar bone density, while periodontal inflammation can elevate the expression of systemic biomarkers of bone resorption, influencing osteoporosis progression. Furthermore, dysbiosis of the gut and oral cavity microbial communities plays a critical role in both conditions. Gut dysbiosis can influence systemic inflammation and bone metabolism, exacerbating osteoporosis, while oral dysbiosis, marked by pathogenic shifts in the microbiota, triggers and perpetuates periodontal inflammation and alveolar bone loss. Understanding these interrelationships emphasizes the need for an integrated approach to preventing and managing these interconnected conditions.
Indexed as
Identifiers
41225098What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.